FLOX-0-ZOLE TAB - Dr Precision

FLOX-0-ZOLE TAB is best indicated for treating mixed bacterial and protozoal infections, including amoebic and bacterial dysentery, giardiasis, pelvic inflammatory disease, bacterial vaginosis, abdominal and post-surgical infections, infective and traveler's diarrhea, as well as dental infections and periodontal abscesses.

Ofloxacin targets aerobic bacteria by inhibiting DNA gyrase and topoisomerase IV enzymes critical for bacterial replication, while Metronidazole is activated under anaerobic conditions to disrupt DNA synthesis in anaerobic bacteria and protozoa. Their combined effect covers a broad spectrum of pathogens including both aerobic and anaerobic bacteria plus protozoal organisms, enabling effective treatment of complex mixed infections.

Yes, FLOX-0-ZOLE TAB is manufactured under WHO-GMP certification by BluepillExpress, adhering to international quality and regulatory standards, making it highly suitable for export and distribution in regulated global pharmaceutical markets.

FLOX-0-ZOLE TAB is produced in WHO-GMP certified facilities under the Dr Precision brand, ensuring stringent compliance with Good Manufacturing Practices, high-quality formulation precision, safety protocols, and quality assurance.

Yes, the Metronidazole component of FLOX-0-ZOLE TAB is highly effective against anaerobic bacteria commonly found in post-surgical infections, while Ofloxacin covers aerobic bacteria, making this tablet suitable for managing such mixed infections.

FLOX-0-ZOLE TAB is provided in export-ready, customizable packaging to meet buyer needs, with a typical shelf life of around 2 years, subject to regulatory compliance and batch-specific certifications.